GENERAL CATALOGUE
REGN5093-M114
HY-171191 · 50 mg
MedChemExpress · Cat: HY-171191
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/regn5093-m114.htmlCatalog No: HY-171191
Category: Antibody-drug Conjugate ADC Related
Pack Size: 50 mg
Brand: MedChemExpress
Description
REGN5093-M114 is a bispecific antibody-drug conjugate ADC that targets two epitopes of the MET receptor tyrosine kinase inhibits the proliferation of NSCLC cells, exhibits antitumor efficacy in mouse models. REGN5093-M114 is composed of the human monoclonal anti-MET antibody Davutamig HY-P990073 and the tubulin-inhibiting linker-payload HY-148528 .
More from MedChemExpress
Rha-PEG3-SMCC
HY-142740
Antibody-drug Conjugate ADC Related
PPC-NB
HY-126530
Antibody-drug Conjugate ADC Related
Taltobulin intermediate-8
HY-41070
Antibody-drug Conjugate ADC Related
m-PEG8-NHS ester
HY-W019793
Antibody-drug Conjugate ADC Related
Mal-amido-PEG5-C2-NHS ester
HY-126508
Antibody-drug Conjugate ADC Related
Tisotumab vedotin
HY-152963
Antibody-drug Conjugate ADC Related
Muscotoxin A
HY-131058
Antibody-drug Conjugate ADC Related
Methylcyclopropene-PEG4-NHS
HY-136048
Antibody-drug Conjugate ADC Related